Form DRS - Draft Registration Statement:
SEC Accession No. 0001570562-17-000005
Filing Date
2017-08-28
Accepted
2017-08-28 14:28:46
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2361287
2 higherreslogowithtma01.jpg GRAPHIC 663123
3 image1a05.jpg GRAPHIC 24435
4 image2a04.jpg GRAPHIC 48784
5 image34.jpg GRAPHIC 56308
6 slide4.jpg GRAPHIC 39223
7 slide6.jpg GRAPHIC 48686
8 slide7.jpg GRAPHIC 35016
9 slide8.jpg GRAPHIC 67557
10 slide11.jpg GRAPHIC 79651
11 slide12.jpg GRAPHIC 77063
12 slide13.jpg GRAPHIC 160030
13 slide14.jpg GRAPHIC 49594
14 slide17.jpg GRAPHIC 38811
15 slide42.jpg GRAPHIC 26887
16 slide91.jpg GRAPHIC 79854
17 slide101.jpg GRAPHIC 79522
18 slide151.jpg GRAPHIC 29582
19 slide161.jpg GRAPHIC 30924
  Complete submission text file 0001570562-17-000005.txt   4605699
Mailing Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614
Business Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01693 | Film No.: 171054243
SIC: 2834 Pharmaceutical Preparations